Pure Global

NPLATE POWDER FOR PREPARING SOLUTION FOR 250 MCG INJECTION, 1 PIECE - Turkey License b09ef1c184970c19846e8f00f93cf9f5

Access comprehensive regulatory information for NPLATE POWDER FOR PREPARING SOLUTION FOR 250 MCG INJECTION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number b09ef1c184970c19846e8f00f93cf9f5 with license number 2022/382and contains active ingredient Romiplostim . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
b09ef1c184970c19846e8f00f93cf9f5
License Details
Turkey SFDA License: b09ef1c184970c19846e8f00f93cf9f5
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

NPLATE POWDER FOR PREPARING SOLUTION FOR 250 MCG INJECTION, 1 PIECE
TR: NPLATE 250 MCG ENJEKSİYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 1 ADET
Pharmaceutical Product

License Details

b09ef1c184970c19846e8f00f93cf9f5

2022/382

8699862270045

B02BX04

License Holder Information

Active Ingredient

Romiplostim

License Information

Jul 06, 2022